{"id":"NCT02756611","sponsor":"AbbVie","briefTitle":"A Study to Evaluate the Efficacy of Venetoclax Monotherapy in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL)","officialTitle":"Open-Label, Single Arm, Phase 3b, Multi-Center Study Evaluating the Efficacy of Venetoclax (ABT 199) in Relapsed/Refractory Subjects With Chronic Lymphocytic Leukemia (CLL)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-06-22","primaryCompletion":"2019-04-10","completion":"2022-03-11","firstPosted":"2016-04-29","resultsPosted":"2020-05-04","lastUpdate":"2023-04-10"},"enrollment":258,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Lymphocytic Leukemia"],"interventions":[{"type":"DRUG","name":"Venetoclax","otherNames":["ABT-199","VENCLEXTA®"]}],"arms":[{"label":"Venetoclax","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy of venetoclax monotherapy in participants with relapsed/refractory CLL with or without the 17p deletion or TP53 mutation, including those who have received prior treatment with a B-cell receptor inhibitor.","primaryOutcome":{"measure":"Complete Remission Rate in Participants Not Previously Treated With BCRi Therapy - Primary Analysis","timeFrame":"From first dose of study drug until the last participant completed Week 48 assessments (data cut-off date 30 June 2019); overall median time on follow-up was 23.2 months.","effectByArm":[{"arm":"Venetoclax","deltaMin":35.1,"sd":null}],"pValues":[{"comp":"OG000","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":8},"locations":{"siteCount":67,"countries":["United States","Austria","Belgium","Canada","Denmark","Finland","France","Germany","Greece","Ireland","Israel","Italy","Netherlands","Norway","Portugal","Puerto Rico","Spain","Sweden","Switzerland","Turkey (Türkiye)","United Kingdom"]},"refs":{"pmids":["38467131"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":136,"n":258},"commonTop":["NEUTROPENIA","DIARRHOEA","NAUSEA","ANAEMIA","THROMBOCYTOPENIA"]}}